Gamida Cell Ltd. (GMDA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 3.2400 |
| Open | 3.2300 |
| Bid | 3.0000 x 800 |
| Ask | 3.1000 x 1300 |
| Day's range | 2.7800 - 3.2900 |
| 52-week range | 2.1000 - 15.0000 |
| Volume | |
| Avg. volume | 916,645 |
| Market cap | 183.826M |
| Beta (5Y monthly) | 1.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More
Regulatory and other pipeline updates from Zogenix (ZGNX) and Regeneron (REGN) are among a few key highlights from the biotech sector during the past week.
- Zacks
Gamida (GMDA) Up on Omidubicel BLA Rolling Submission Plan
The FDA agrees to the initiation of rolling submission of Gamida's (GMDA) BLA for its lead blood cancer candidate, omidubicel. The stock rises more than 22% on in response.
- Motley Fool
Gamida Cell Ltd. (GMDA) Q3 2021 Earnings Call Transcript
Please be advised that this call is being recorded at Gamida Cell's request. Now, I would like to introduce your host for today's conference, Mr. Josh Hamermesh, chief business officer. Welcome to today's call, during which we will provide an update on the company and review our financial results for the third quarter of 2021.
© 2022 Yahoo. All rights reserved.
